Delphinus Medical Technologies is a medical technology company that develops and manufactures advanced breast ultrasound imaging systems. The company was founded in 2009 and is headquartered in Plymouth, Michigan. Delphinus Medical Technologies' flagship product is the SoftVue system, which uses a unique ring transducer to provide high-resolution images of the breast. The SoftVue system is designed to be more comfortable and less invasive than traditional mammography. Delphinus Medical Technologies is committed to improving breast cancer detection and reducing false positives. The company has received funding from a variety of sources, including venture capital firms and the National Institutes of Health.